SP481DALTEPARIN SODIUM FOR THE PREVENTION OF CLOTTING IN THE EXTRACORPOREAL CIRCUIT DURING HEMODIALYSIS: A PHASE IIIB OPEN-LABEL STUDY TO OPTIMIZE A SINGLE BOLUS DOSE—THE PARROT STUDY

Safety of the adjuvanted recombinant zoster vaccine in adults aged 50 years or older. A phase IIIB, non-randomized, multinational, open-label study in previous ZOE-50 and ZOE-70 placebo recipients

Vaccine ◽

10.1016/j.vaccine.2020.10.029 ◽

2021 ◽

Vol 39 (1) ◽

pp. 6-10

Author(s):

Josephine Ocran-Appiah ◽

Céline Boutry ◽

Caroline Hervé ◽

Jyoti Soni ◽

Anne Schuind

Keyword(s):

Zoster Vaccine ◽

Open Label ◽

Open Label Study ◽

Label Study ◽

Phase Iiib ◽

Recombinant Zoster Vaccine ◽

Placebo Recipients

Abstract P5-19-06: 4EVER - Final efficacy analysis of the phase IIIb, multi-center, open label study for postmenopausal women with estrogen receptor positive locally advanced or metastatic breast cancer (BC) treated with everolimus (EVE) in combination with exemestane (EXE)

10.1158/1538-7445.sabcs14-p5-19-06 ◽

2015 ◽

Author(s):

Hans Tesch ◽

Oliver J Stoetzer ◽

Thomas Decker ◽

Christian M Kurbacher ◽

Romy Neumeister ◽

...

Keyword(s):

Breast Cancer ◽

Estrogen Receptor ◽

Locally Advanced ◽

Metastatic Breast ◽

Open Label ◽

Open Label Study ◽

Label Study ◽

Efficacy Analysis ◽

Phase Iiib ◽

Interim analysis from a phase IIIb, open-label study of afatinib in EGFR TKI-naïve patients (pts) with EGFR mutation-positive (EGFRm+) NSCLC

Annals of Oncology ◽

10.1093/annonc/mdz437.008 ◽

2019 ◽

Vol 30 ◽

pp. ix161-ix162

Author(s):

F. De Marinis ◽

K.K. Laktionov ◽

A. Poltoratskiy ◽

I. Egorova ◽

M. Hochmair ◽

...

Keyword(s):

Interim Analysis ◽

Egfr Mutation ◽

Open Label ◽

Open Label Study ◽

Label Study ◽

Phase Iiib ◽

RIBECCA: A phase IIIb, multi-center, open label study for women with estrogen receptor positive locally advanced or metastatic breast cancer treated with ribociclib (LEE011) in combination with letrozole—Results of the first interim analysis.

Journal of Clinical Oncology ◽

10.1200/jco.2018.36.15_suppl.1051 ◽

2018 ◽

Vol 36 (15_suppl) ◽

pp. 1051-1051

Author(s):

Peter A. Fasching ◽

Arnd Nusch ◽

Bernhard Heinrich ◽

Sara Brucker ◽

Thomas Decker ◽

...

Keyword(s):

Breast Cancer ◽

Estrogen Receptor ◽

Interim Analysis ◽

Locally Advanced ◽

Metastatic Breast ◽

Open Label ◽

Open Label Study ◽

Label Study ◽

Phase Iiib ◽

EP1.14-49 A Phase IIIb Open-Label Study of Afatinib in EGFR TKI-Naïve Patients with EGFRm+ NSCLC: Exploratory Biomarker Analysis

Journal of Thoracic Oncology ◽

10.1016/j.jtho.2019.08.2334 ◽

2019 ◽

Vol 14 (10) ◽

pp. S1050-S1051

Author(s):

J. Wang ◽

J. Zhao ◽

H. Bai ◽

X. Wang ◽

Y. Wang ◽

...

Keyword(s):

Open Label ◽

Open Label Study ◽

Label Study ◽

Biomarker Analysis ◽

Phase Iiib ◽

P2.14-58 A Phase IIIb, Open-Label Study of Afatinib in Caucasian EGFR TKI-Naïve Patients with EGFRm+ NSCLC: An Interim Analysis

Journal of Thoracic Oncology ◽

10.1016/j.jtho.2019.08.1843 ◽

2019 ◽

Vol 14 (10) ◽

pp. S853-S854

Author(s):

F. De Marinis ◽

K.K. Laktionov ◽

A. Poltoratskiy ◽

I. Egorova ◽

M.J. Hochmair ◽

...

Keyword(s):

Interim Analysis ◽

Open Label ◽

Open Label Study ◽

Label Study ◽

Phase Iiib ◽

Abstract OT2-6-09: 4EVER - A phase IIIb, multi-center, open label study for postmenopausal women with estrogen receptor positive locally advanced or metastatic breast cancer (BC) treated with everolimus (EVE) in combination with exemestane (EXE)

10.1158/0008-5472.sabcs13-ot2-6-09 ◽

2013 ◽

Author(s):

H Tesch ◽

PA Fasching ◽

P Hadji ◽

DI Lueftner ◽

W Janni ◽

...

Keyword(s):

Breast Cancer ◽

Estrogen Receptor ◽

Metastatic Breast Cancer ◽

Locally Advanced ◽

Metastatic Breast ◽

Open Label ◽

Open Label Study ◽

Label Study ◽

Phase Iiib ◽

Abstract OT2-01-18: RIBECCA - A phase IIIb, multi-center, open label study for women with estrogen receptor positive locally advanced or metastatic breast cancer treated with ribociclib (LEE011) in combination with letrozole

10.1158/1538-7445.sabcs16-ot2-01-18 ◽

2017 ◽

Cited By ~ 2

Author(s):

PA Fasching ◽

T Decker ◽

T Fehm ◽

W Janni ◽

S Kuemmel ◽

...

Keyword(s):

Breast Cancer ◽

Estrogen Receptor ◽

Metastatic Breast Cancer ◽

Locally Advanced ◽

Metastatic Breast ◽

Open Label ◽

Open Label Study ◽

Label Study ◽

Phase Iiib ◽

P2.01-99 A Phase IIIb Open-Label Study of Afatinib in EGFR TKI-Naïve Patients with EGFR Mutation-Positive NSCLC: Final Analysis

Journal of Thoracic Oncology ◽

10.1016/j.jtho.2019.08.1442 ◽

2019 ◽

Vol 14 (10) ◽

pp. S679-S680 ◽

Cited By ~ 1

Author(s):

Y. Wu ◽

H. Tu ◽

J. Feng ◽

M. Shi ◽

J. Zhao ◽

...

Keyword(s):

Egfr Mutation ◽

Final Analysis ◽

Open Label ◽

Open Label Study ◽

Label Study ◽

Phase Iiib ◽

A phase IIIb open-label study of afatinib in EGFR TKI-naïve patients (pts) with EGFR mutation-positive (EGFRm+) NSCLC: Exploratory biomarker analysis

Annals of Oncology ◽

10.1093/annonc/mdz436.001 ◽

2019 ◽

Vol 30 ◽

pp. ix153-ix154

Author(s):

J. Wang ◽

J. Zhao ◽

H. Bai ◽

X. Wang ◽

Y. Wang ◽

...

Keyword(s):

Egfr Mutation ◽

Open Label ◽

Open Label Study ◽

Label Study ◽

Biomarker Analysis ◽

Phase Iiib ◽